Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults

BACKGROUND: We compared homologous and heterologous boosting in adults in the Philippines primed with 2 or 3 doses of CoronaVac, with recombinant protein vaccine, SCB-2019. METHODS: CoronaVac-immunized adults (18–72 years) received a homologous or heterologous full or half dose SCB-2019 booster. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Roa, Camilo C, de Los Reyes, Mari Rose A, Plennevaux, Eric, Smolenov, Igor, Hu, Branda, Gao, Faith, Ilagan, Hannalyn, Ambrosino, Donna, Siber, George, Clemens, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629704/
https://www.ncbi.nlm.nih.gov/pubmed/37439701
http://dx.doi.org/10.1093/infdis/jiad262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629704/
https://www.ncbi.nlm.nih.gov/pubmed/37439701
http://dx.doi.org/10.1093/infdis/jiad262

Ejemplares similares